Keep Me Logged In
John Lechleiter, Eli Lilly CEO, breaks down the pharma giant's numbers and discusses new products in the pipeline, and provides an update on its diabetes drug, Humalog.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2019 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by